Le marché des médicaments contre l'asthme devrait atteindre 34 136,10 millions de dollars US en 2028 contre 24 239,17 millions de dollars US en 2021 ; on estime qu'il augmentera à un TCAC de 5,0 % entre 2021 et 2028.
L'asthme est une maladie pulmonaire qui touche les personnes de tous âges. Il produit une respiration sifflante et rend la respiration difficile. L'exposition à une allergie ou à un irritant, aux infections, à l'exercice, au stress émotionnel et à d'autres conditions sont tous des déclencheurs potentiels. Lorsque les symptômes de l'asthme deviennent insupportables, une crise d'asthme s'ensuit. Les attaques peuvent survenir de nulle part et vont de légères à potentiellement mortelles. L'asthme est géré avec des inhalateurs de secours pour traiter les symptômes et des inhalateurs de contrôle qui préviennent les symptômes. Les cas graves peuvent nécessiter des inhalateurs à action prolongée qui maintiennent les voies respiratoires ouvertes (formotérol, salmétérol, tiotropium) et des stéroïdes inhalés. Les médicaments contre l'asthme se présentent sous plusieurs formes, y compris les comprimés, les injections, les liquides et les inhalateurs, et ils se répartissent en deux groupes, tels que les bronchodilatateurs et les anti-inflammatoires.
Le marché des médicaments contre l'asthme est segmenté en fonction du médicament, de la voie d'administration, du canal de distribution et de la géographie. Le marché, basé sur la géographie, est largement segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport sur le marché des médicaments contre l'asthme offre des informations et une analyse approfondie du marché, en mettant l'accent sur des paramètres tels que la taille, les tendances et la dynamique du marché; les progrès technologiques sur le marché ; et l'analyse du paysage concurrentiel des principaux acteurs du marché des médicaments contre l'asthme.
Perspectives stratégiques
Quelques facteurs tels car les implications environnementales et génétiques croissantes de la pollution de l'air, la vulnérabilité accrue de groupes ethniques spécifiques, l'exposition croissante aux particules grossières, la prévalence croissante des troubles physiologiques abritant l'asthme devraient avoir un impact significatif à court, moyen et long terme sur le marché des médicaments contre l'asthme dans les années à venir. Cependant, les besoins médicaux non satisfaits et le manque d'observance du traitement entravent la croissance du marché. Le rapport de marché identifie les opportunités et les tendances futures du marché qui peuvent avoir des impacts possibles sur la croissance du marché.
Régions lucratives sur le marché des médicaments contre l'asthme
Aperçu du marché
Implications environnementales croissantes et implications génétiques de la pollution de l'air
L'asthme est une affection respiratoire chronique caractérisée par une restriction fluctuante du débit d'air, une hyperréactivité bronchique et inflammation des voies respiratoires. Selon un article de synthèse intitulé “Impact of Air Pollution on Asthma Outcomes” par Tiotiu et al., la pollution de l'air a entravé les résultats de l'asthme chez les adultes et les enfants. La pollution atmosphérique due à la circulation, le dioxyde d'azote (NO
2
) et le tabagisme passif (SHS) sont tous des facteurs de risque importants pour le développement de l'asthme chez les enfants. Les symptômes de l'asthme, les exacerbations et la diminution de la fonction pulmonaire peuvent être déclenchés par l'exposition à la pollution extérieure.
Aux États-Unis, l'exposition à la pollution de l'air continue d'être associée à l'asthme. Cette maladie respiratoire chronique grave et potentiellement mortelle a un impact sur la qualité de vie de plus de 23 millions de citoyens américains. La pollution de l'air peut aggraver les symptômes de l'asthme, déclenchant des crises d'asthme chez les personnes. Les enfants asthmatiques, qui touchent environ 6 millions d'enfants aux États-Unis, sont particulièrement vulnérables à la pollution.
Une nouvelle étude financée par l'Environmental Protection Agency (EPA) a analysé le lien entre l'air Pollution et asthme. Bien que les experts ne puissent pas déterminer le principal agent responsable de l'asthme en raison de la pollution de l'air, les preuves suggèrent qu'il supprime les gènes qui contrôlent le système immunitaire pour faire la distinction entre un allergène et une substance étrangère dangereuse, comme un virus ou une bactérie. Le système immunitaire s'emballe alors, déclenchant une réaction inflammatoire, que le médicament soit toxique ou non, entraînant de l'asthme.
Des chercheurs du Centre pour enfants de l'Université de Stanford ont étudié l'effet de la pollution de l'air sur deux gènes impliqués dans la tolérance immunologique chez les enfants d'une zone fortement polluée. Ils ont découvert que l'exposition à court et à long terme à de grandes quantités de monoxyde de carbone (CO), de NO
2
et de PM
2,5
(matières particulaires) étaient liées à des changements dans ces deux gènes, qui ont causé l'asthme. Ces découvertes se sont concentrées sur les impacts épigénétiques de l'exposition à la pollution de l'air et pourraient aider au développement de médicaments préventifs contre l'asthme.
Chacune de ces recherches sur l'asthme a amélioré la compréhension de l'asthme chez les enfants et fourni des informations cruciales à l'EPA qui peuvent être utilisées pour protéger la santé humaine et l'environnement. Grâce à ces travaux de recherche, la découverte et le développement de médicaments pour l'asthme sont accélérés, ce qui stimule le marché des médicaments contre l'asthme.
Informations basées sur le type de médicament
< CONSEIL>
Le marché mondial des médicaments contre l'asthme, basé sur les médicaments, est divisé en médicaments de soulagement rapide et en médicaments de contrôle à long terme. Le segment des médicaments de contrôle à long terme devrait détenir une plus grande part de marché dans les années à venir. Cependant, le segment des médicaments de secours rapide devrait enregistrer un TCAC plus élevé au cours de la période de prévision.
Marché des médicaments contre l'asthme, par médicament - 2021 et 2028
< TIP>
Voie d'information basée sur l'administration
En fonction de la voie d'administration, le marché des médicaments contre l'asthme est segmenté en seringues/flacons inhalés, préremplis et autres. Le segment inhalé détenait la plus grande part du marché en 2021 et devrait détenir une part importante au cours de la période de prévision. Cependant, le segment des seringues/flacons préremplis devrait enregistrer le TCAC le plus élevé de 2021 à 2028.
Insights basés sur les canaux de distribution
Sur la base du canal de distribution, le marché des médicaments contre l'asthme est segmenté en pharmacies en ligne, pharmacies hospitalières et pharmacies de détail. Le segment des pharmacies de détail devrait détenir la plus grande part du marché au cours de la période de prévision. Cependant, le segment des pharmacies en ligne devrait enregistrer le TCAC le plus élevé de 2021 à 2028.
Diverses entreprises opérant sur le marché des médicaments contre l'asthme adoptent des stratégies telles que les lancements de produits, les fusions et acquisitions, des collaborations, des innovations de produits et des extensions de portefeuille de produits pour étendre leur empreinte dans le monde entier, maintenir un nom de marque et répondre aux demandes croissantes des consommateurs. Certains des principaux acteurs présents sur le marché sont AstraZeneca ; Teva Pharmaceutical Industries Ltd. ; GlaxoSmithKline PLC ; Boehringer Ingelheim International GmbH ; Merck & Co., Inc. ; Koninklijke Philips NV ; Sanofi ; Pfizer Inc. ; Novartis SA ; et Abbott.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.
The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.
The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.
The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.
The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.
On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.
The List of Companies - Asthma Drugs Market
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Koninklijke Philips NV
- Sanofi
- Pfizer Inc.
- Novartis AG
- Abbott
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)